3 Results for "

PD-1-IN-17

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "PD-1-IN-17" in MCE Product Catalog:

Cat. No.: HY-101097
CAS No.: 1673560-66-1
Purity:  99.57%
Target:  

PD-1/PD-L1

Research Areas:  

Cancer

PD-1-IN-17 is a programmed cell death-1 (PD-1) inhibitor extracted from patent WO2015033301A1, Compound 12, inhibits 92% splenocyte proliferation at 100 nM .
loading...
    loading...
Cat. No.: HY-113512
CAS No.: 90780-52-2
Purity:  98.8%
17-HDHA is a DHA-derived specialized pro-resolving mediator (SPM). 17-HDHA inhibits NF-κB activation by activating PPARγ and upregulating IκBα, targets FPR2 and Bcl-6, and also acts as a precursor of RvD1 and PD1. 17-HDHA inhibits pulmonary artery smooth muscle cell proliferation, regulates the expression of adiponectin, GLUT-4 and inflammatory cytokines, suppresses IgE production by B cells and promotes antibody secretion. 17-HDHA reduces adipose tissue inflammation, improves insulin sensitivity and glucose tolerance, alleviates pathological processes associated with pulmonary hypertension, and enhances antibody responses and virus neutralizing activity against influenza HA. 17-HDHA can be used in research related to obesity-associated inflammation, insulin resistance, glucose intolerance, pulmonary hypertension and influenza virus infection .
loading...
    loading...
Cat. No.: HY-101097A
Target:  

PD-1/PD-L1

Research Areas:  

Cancer

PD-1-IN-17 TFA is a programmed cell death-1 (PD-1) inhibitor extracted from patent WO2015033301A1, Compound 12, inhibits 92% splenocyte proliferation at 100 nM .
loading...
    loading...